Literature DB >> 22085703

Back to your heart: ubiquitin proteasome system-regulated signal transduction.

Andrea L Portbury1, Sarah M Ronnebaum, Makhosazane Zungu, Cam Patterson, Monte S Willis.   

Abstract

Awareness of the regulation of cell signaling by post-translational ubiquitination has emerged over the past 2 decades. Like phosphorylation, post-translational modification of proteins with ubiquitin can result in the regulation of numerous cellular functions, for example, the DNA damage response, apoptosis, cell growth, and the innate immune response. In this review, we discuss recently published mechanisms by which the ubiquitin proteasome system regulates key signal transduction pathways in the heart, including MAPK JNK, calcineurin, FOXO, p53, and estrogen receptors α and β. We then explore how ubiquitin proteasome system-specific regulation of these signal transduction pathways plays a role in the pathophysiology of common cardiac diseases, such as cardiac hypertrophy, heart failure, ischemia reperfusion injury, and diabetes. This article is part of a Special Section entitled "Post-translational Modification."
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085703      PMCID: PMC3294005          DOI: 10.1016/j.yjmcc.2011.10.023

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  156 in total

1.  Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity.

Authors:  Lijin Feng; Tongxiang Lin; Hiroaki Uranishi; Wei Gu; Yang Xu
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

2.  Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury.

Authors:  Erin A Booth; Nabeel R Obeid; Benedict R Lucchesi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-01       Impact factor: 4.733

3.  Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts.

Authors:  Jinbao Liu; Quanhai Chen; Wei Huang; Kathleen M Horak; Hanqiao Zheng; Ruben Mestril; Xuejun Wang
Journal:  FASEB J       Date:  2005-12-21       Impact factor: 5.191

4.  The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation.

Authors:  Kurt A Krummel; Crystal J Lee; Franck Toledo; Geoffrey M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

5.  Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.

Authors:  Stefan Weger; Eva Hammer; Regine Heilbronn
Journal:  FEBS Lett       Date:  2005-09-12       Impact factor: 4.124

6.  Ubiquitination of p53 at multiple sites in the DNA-binding domain.

Authors:  Wan Mui Chan; Man Chi Mak; Tsz Kan Fung; Anita Lau; Wai Yi Siu; Randy Y C Poon
Journal:  Mol Cancer Res       Date:  2006-01       Impact factor: 5.852

7.  Regulation of the proapoptotic factor FOXO1 (FKHR) in cardiomyocytes by growth factors and alpha1-adrenergic agonists.

Authors:  James B Morris; Bronwyn Kenney; Huy Huynh; Elizabeth A Woodcock
Journal:  Endocrinology       Date:  2005-07-14       Impact factor: 4.736

8.  ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.

Authors:  Delin Chen; Ning Kon; Muyang Li; Wenzhu Zhang; Jun Qin; Wei Gu
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

Review 9.  Structural basis of ventricular remodeling: role of the myocyte.

Authors:  Faqian Li; Xuejun Wang; Xian Ping Yi; A Martin Gerdes
Journal:  Curr Heart Fail Rep       Date:  2004 Apr-May

10.  CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.

Authors:  Meiyun Fan; Annie Park; Kenneth P Nephew
Journal:  Mol Endocrinol       Date:  2005-07-21
View more
  44 in total

1.  Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure.

Authors:  Viswanathan Rajagopalan; Mingming Zhao; Sushma Reddy; Giovanni Fajardo; Xuejun Wang; Shannamar Dewey; Aldrin V Gomes; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-31       Impact factor: 4.733

2.  Proteasome regulates the mediators of cytoplasmic polyadenylation signaling during late-phase long-term potentiation.

Authors:  Chenghai Dong; Anirudh Vashisht; Ashok N Hegde
Journal:  Neurosci Lett       Date:  2014-09-28       Impact factor: 3.046

Review 3.  Programming apoptosis and autophagy with novel approaches for diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

4.  Relationship between the proteasomal system and autophagy.

Authors:  Alain Lilienbaum
Journal:  Int J Biochem Mol Biol       Date:  2013-03-31

5.  The expanding world of post-translational modifications.

Authors:  Elizabeth Murphy; Cam Patterson
Journal:  J Mol Cell Cardiol       Date:  2012-01-11       Impact factor: 5.000

Review 6.  Post-translational and post-transcriptional modifications of pregnane X receptor (PXR) in regulation of the cytochrome P450 superfamily.

Authors:  Tomas Smutny; Sridhar Mani; Petr Pavek
Journal:  Curr Drug Metab       Date:  2013-12       Impact factor: 3.731

Review 7.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

Review 8.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

9.  MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.

Authors:  Kedryn K Baskin; Meredith R Rodriguez; Seema Kansara; Wenhao Chen; Sylvia Carranza; O Howard Frazier; David J Glass; Heinrich Taegtmeyer
Journal:  J Mol Cell Cardiol       Date:  2014-03-18       Impact factor: 5.000

Review 10.  FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.